We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
World Acceptance Corp
WRLD
$873M
| $1.28M | ﹤0.01% |
13,235
-114
| -0.9% | -$13.2K |
|
|
BRG
2602
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $1.28M | ﹤0.01% |
91,964
+7,894
| +9% | +$208K |
|
2603
Fulcrum Therapeutics
FULC
$297M
| $1.28M | ﹤0.01% |
158,206
-242,936
| -61% | -$1.74M |
|
2604
Sutro Biopharma
STRO
$421M
| $1.28M | ﹤0.01% |
23,060
-87
| -0.4% | -$5.15K |
|
2605
Farmers National Banc Corp
FMNB
$930M
| $1.28M | ﹤0.01% |
97,637
-1,536
| -2% | -$22.2K |
|
2606
RE/MAX Holdings
RMAX
$242M
| $1.28M | ﹤0.01% |
67,537
-585
| -0.9% | -$13.9K |
|
2607
Merchants Bancorp
MBIN
$2.49B
| $1.28M | ﹤0.01% |
55,303
-2,771
| -5% | -$71K |
|
2608
Financial Institutions
FISI
$821M
| $1.27M | ﹤0.01% |
52,981
-438
| -0.8% | -$11.4K |
|
|
FORG
2609
DELISTED
ForgeRock, Inc.
FORG
| $1.27M | ﹤0.01% |
87,668
+26,375
| +43% | +$507K |
|
2610
PetMed Express
PETS
$42.3M
| $1.27M | ﹤0.01% |
65,081
-107
| -0.2% | -$2.27K |
|
2611
Cardlytics
CDLX
$21.5M
| $1.26M | ﹤0.01% |
13,440
+323
| +2% | +$46K |
|
|
CD
2612
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $1.26M | ﹤0.01% |
155,600
+7,100
| +5% | +$54.7K |
|
|
BRT
2613
BRT Apartments
BRT
$271M
| $1.25M | ﹤0.01% |
61,710
+125
| +0.2% | +$2.85K |
|
2614
1-800-Flowers.com
FLWS
$258M
| $1.25M | ﹤0.01% |
192,543
-1,533
| -0.8% | -$13.6K |
|
2615
Invesco Mortgage Capital
IVR
$805M
| $1.25M | ﹤0.01% |
113,558
-2,513
| -2% | -$39.1K |
|
2616
Organogenesis Holdings
ORGO
$239M
| $1.25M | ﹤0.01% |
384,847
-16,318
| -4% | -$73.7K |
|
2617
CNB Financial Corp
CCNE
$1.03B
| $1.25M | ﹤0.01% |
52,846
-3,719
| -7% | -$95.2K |
|
|
GPMT
2618
Granite Point Mortgage Trust
GPMT
$61.2M
| $1.24M | ﹤0.01% |
193,055
-4,141
| -2% | -$39.2K |
|
2619
Ocugen
OCGN
$434M
| $1.24M | ﹤0.01% |
696,254
-14,825
| -2% | -$36.9K |
|
2620
Beazer Homes USA
BZH
$907M
| $1.23M | ﹤0.01% |
126,991
-3,571
| -3% | -$49K |
|
2621
National Presto Industries
NPK
$989M
| $1.23M | ﹤0.01% |
18,859
-299
| -2% | -$20.7K |
|
2622
HUTCHMED
HCM
$2.17B
| $1.22M | ﹤0.01% |
137,780
| – | – |
|
2623
Telos
TLS
$358M
| $1.22M | ﹤0.01% |
137,332
-66,953
| -33% | -$617K |
|
|
SRG
2624
Seritage Growth Properties
SRG
$136M
| $1.22M | ﹤0.01% |
135,121
-6,135
| -4% | -$70.2K |
|
|
SFIX
2625
Stitch Fix
SFIX
$560M
| $1.21M | ﹤0.01% |
307,309
-734
| -0.2% | -$4.17K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.